Hematology/Oncology

Top Story

Dana-Farber Cancer Institute appoints gastrointestinal cancer center director

Dana-Farber Cancer Institute appoints gastrointestinal cancer center director
May 27, 2017

Brian Wolpin , MD, MPH, has been appointed director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute.

Wolpin is chair in pancreatic cancer at Dana-Farber, as well as associate professor of medicine at Harvard Medical School. He also has served as co-director of the Pancreas and Biliary Tumor Center at Dana-Farber/Brigham and Women’s Cancer Center.

FDA News

FDA expands approval of Zykadia for ALK–positive metastatic NSCLC

May 26, 2017
The FDA expanded the approval of ceritinib to include the first-line treatment of patients with metastatic non–small cell lung cancer, according to the…
In the Journals Plus

Reduced-intensity, standard conditioning demonstrate comparable transplant outcomes in myelodysplastic syndrome

May 26, 2017
A reduced-intensity conditioning regimen yielded comparable RFS and OS as standard myeloablative conditioning among patients with myelodysplastic syndrome, according to…
FDA News

Eight FDA updates

May 26, 2017
The FDA has announced several decisions and opinions related to hematology and oncology in the past month. HemOnc Today summarizes eight FDA actions that may be…
In the Journals Plus

Elevated glucose levels, diabetes may reduce risk for glioma

May 26, 2017
Researchers observed an inverse relationship between blood glucose levels and risk for glioma, according to an analysis of two study cohorts published in Scientific
More News Headlines »
CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Video
Meeting News

VIDEO: Cappelli discusses autoimmune complications from cancer therapy

April 8, 2017
More »
Featured
ASCO Annual Meeting

ASCO Annual Meeting

CME

Immune Checkpoint Inhibitors for Advanced Melanoma: Clinical Updates and Multidisciplinary Strategies

This activity is supported by an educational grant from Bristol-Myers Squibb.

Incidence rates of melanoma in the United States continue to rise, with an estimated 87,110 new cases being diagnosed…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement